ENDRA Life Sciences (NDRA) Accounts Payables (2016 - 2026)
ENDRA Life Sciences (NDRA) posted quarterly Accounts Payables of $701487.0 for Q1 2026, up 59.54% year-over-year from $439688.0 in Q1 2025, and up 12.86% quarter-over-quarter from $621578.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Accounts Payables (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Accounts Payables for 11 consecutive years, with $701487.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Accounts Payables rose 59.54% year-over-year to $701487.0; the TTM figure through Mar 2026 stood at $701487.0 (up 59.54% YoY), while the FY2025 annual figure was $621578.0, up 22.29% from the prior year.
- Accounts Payables improved to $701487.0 in Q1 2026 per NDRA's latest filing, from $621578.0 in the prior quarter.
- Across five years, Accounts Payables topped out at $2.0 million in Q3 2023 and bottomed at $439688.0 in Q1 2025.
- Historically, Accounts Payables has averaged $1.1 million across 5 years, with a median of $1.0 million in 2024.
- Annual changes were most pronounced in 2022 — Accounts Payables soared 77.8% — and 2024, when it tumbled 68.23%.
- ENDRA Life Sciences' Accounts Payables stood at $1.5 million in 2022, then sank by 53.99% to $700754.0 in 2023, then fell by 27.46% to $508293.0 in 2024, then rose by 22.29% to $621578.0 in 2025, then climbed by 12.86% to $701487.0 in 2026.
- Business Quant data shows NDRA's Accounts Payables at $701487.0 in Q1 2026, $621578.0 in Q4 2025, and $671516.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.27 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 1.82 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 75.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 615.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 129.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 230.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 229.80 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 688.50 Mn |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | 647,934.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 647,934.00 |
| Mar 31, 2026 | 701,487.00 |
| Dec 31, 2025 | 621,578.00 |
| Sep 30, 2025 | 671,516.00 |
| Jun 30, 2025 | 448,419.00 |
| Mar 31, 2025 | 439,688.00 |
| Dec 31, 2024 | 508,293.00 |
| Sep 30, 2024 | 626,706.00 |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 700,754.00 |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.41 Mn |
| Sep 30, 2021 | 1.45 Mn |